Biomerica (BMRA) announced that its Fortel Kidney Disease Test has been approved for sale by the United Arab Emirates Ministry of Health and Prevention. This key regulatory milestone enables Biomerica to offer its test across the UAE, a region facing a high burden of chronic kidney disease.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMRA: